Cimetidine absorption in humans during sucralfate coadministration

Area of Science:

• Pharmacokinetics
• Gastroenterology

Background:

• Cimetidine is a widely used medication for acid-related gastrointestinal conditions.
• Sucralfate is a cytoprotective agent used to treat peptic ulcers.
• Potential drug interactions between cimetidine and sucralfate warrant investigation.

Purpose of the Study:

• To evaluate the effect of sucralfate on the absorption of cimetidine.
• To determine if coadministration alters cimetidine's pharmacokinetic profile.

Main Methods:

• A pharmacokinetic study involving six healthy subjects.
• Single oral 300 mg dose of cimetidine administered.
• Cimetidine absorption assessed in the absence and presence of sucralfate.
• Sucralfate administered for 2 days prior and on the day of cimetidine dosing.

Main Results:

• Sucralfate coadministration did not significantly impact the rate of cimetidine absorption.
• The extent of cimetidine absorption was not statistically influenced by sucralfate.
• No significant difference in key pharmacokinetic parameters was observed.

Conclusions:

• Sucralfate does not appear to alter cimetidine absorption.
• Cimetidine can likely be coadministered with sucralfate without significant pharmacokinetic interactions.
• Further studies may explore effects in patient populations or with different dosing regimens.